SRPT
Sarepta Therapeutics Inc
NASDAQ: SRPT · HEALTHCARE · BIOTECHNOLOGY
$15.54
+0.68% today
Updated 2026-07-29
Market cap
$1.78B
P/E ratio
48.09
P/S ratio
0.81x
EPS (TTM)
$0.35
Dividend yield
—
52W range
$10 – $25
Volume
3.4M
Sarepta Therapeutics Inc (SRPT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$15.54
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.7B | $0.9B | $1.2B | $1.9B | $2.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 2.98%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.